Advantages of Non-Human Adenoviruses Versus Human Adenoviruses Promoter Attenuation in Gene Therapy: Causes and Remedies
- 20 November 1997
- journal article
- editorial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (17) , 2007-2010
- https://doi.org/10.1089/hum.1997.8.17-2007
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- The TMC Worldwide Gene Therapy Enrollment Report, End 1996. Report of TMC Development, Paris, FranceHuman Gene Therapy, 1997
- A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.Proceedings of the National Academy of Sciences, 1996
- Interferon-γ Inhibits Transgene Expression Driven by SV40 or CMV Promoters but Augments Expression Driven by the Mammalian MHC I PromoterHuman Gene Therapy, 1995
- Interferon-α Inhibits the Murine Cytomegalovirus Immediate-Early Gene Expression by Down-Regulating NF-κB ActivityVirology, 1995
- Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor kappa B and induction of human cytomegalovirus enhancer.Journal of Biological Chemistry, 1994
- Tumour necrosis factor stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cellsJournal of General Virology, 1993
- Induction of SV40 Early Transcription by Type I InterferonExperimental Cell Research, 1993